Table 2.
MIC (μg/mL) | |||||
---|---|---|---|---|---|
Isolates codes | Before induction | After induction | # of passages* | ||
Antimicrobial IG | MIC (μg/mL) | Ciprofloxacin | Levofloxacin | ||
PSA-154 | Ciprofloxacin | 0.125 | 256 | >512 | 4 |
Levofloxacin | 0.5 | 32 | 256 | 3 | |
PSA-021 | Ciprofloxacin | <0.0625 | 32 | 1 | 5 |
Levofloxacin | 0.25 | 16 | 32 | 4 | |
PSA-173b | Ciprofloxacin | 0.25 | 64 | 64 | 3 |
Levofloxacin | 0.5 | 16 | 64 | 3 | |
PSA-173a | Ciprofloxacin | 0.25 | 32 | 64 | 3 |
Levofloxacin | 0.5 | 16 | 32 | 3 | |
PSA-115 | Ciprofloxacin | 0.125 | 32 | 64 | 4 |
Levofloxacin | 0.5 | 8 | 32 | 3 | |
PSA-276 | Ciprofloxacin | 0.125 | 16 | 16 | 4 |
Levofloxacin | 0.5 | 32 | 256 | 3 | |
PSA-242 | Ciprofloxacin | 0.25 | 16 | 16 | 3 |
Levofloxacin | 0.5 | 8 | 64 | 3 | |
PSA-025 | Ciprofloxacin | 0.125 | 256 | 512 | 4 |
Levofloxacin | 0.5 | 4 | 32 | 3 | |
PSA-026 | Ciprofloxacin | 0.25 | 32 | 64 | 3 |
Levofloxacin | 0.5 | 16 | 64 | 3 | |
PSA-186 | Ciprofloxacin | 0.125 | 32 | 128 | 4 |
Levofloxacin | 0.5 | 32 | 128 | 3 | |
PSA-118a | Ciprofloxacin | 0.25 | 128 | >512 | 3 |
Levofloxacin | 0.5 | 32 | 128 | 3 | |
PSA-192 | Ciprofloxacin | 0.125 | 16 | 32 | 4 |
Levofloxacin | 0.25 | 2 | 32 | 4 | |
PSA-182 | Ciprofloxacin | 0.125 | 16 | 32 | 4 |
Levofloxacin | 0.5 | 1 | 16 | 3 | |
PSA-058 | Ciprofloxacin | 0.125 | 32 | 32 | 4 |
Levofloxacin | 0.5 | 8 | 32 | 3 | |
PSA-285b | Ciprofloxacin | 0.125 | 32 | 64 | 4 |
Levofloxacin | 0.5 | 4 | 32 | 3 | |
PSA-113a | Ciprofloxacin | 0.25 | 128 | 128 | 3 |
Levofloxacin | 0.5 | 16 | 64 | 3 | |
PSA-124 | Ciprofloxacin | 0.25 | 16 | 16 | 3 |
Levofloxacin | 0.5 | 16 | 16 | 3 | |
PSA-092 | Ciprofloxacin | 0.125 | 64 | 128 | 4 |
Levofloxacin | 0.25 | 8 | 16 | 4 | |
PSA-146b | Ciprofloxacin | 0.125 | 32 | 64 | 4 |
Levofloxacin | 0.5 | 16 | 32 | 3 |
IG, induced against; *, each passage represents a 2-fold increase in the MIC and the numbers indicate the passages required to reach each antibiotic breakpoint.